Abstract With the increasing prevalence of alcohol-related diseases, expanding our understanding of the toxic effects of excessive alcohol consumption is critical for prevention and treatment of metabolic and inflammatory pathology
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
GHK-Cu is a tripeptide with the amino acid sequence glycine-histidine-lysine that possesses a high affinity for copper(II) ions
Learn about growth factor peptides and their synergistic mechanisms
Low blood sugar can cause symptoms such as weakness, dizziness, and fatigue
Microbiome 13 , 167 (2025)